CVS Health Corporation Competitors & Alternatives
CVS Health Corporation competitors and alternatives include UnitedHealth Group Incorporated, etc.…
Jump
-
Stock Price
-
Market Cap
-
Employees
-
Income Statement
-
Revenue
-
Revenue by Product / Services
-
Revenue by Geography
-
Research and Development
-
Operating Income
-
Tax Rate (%)
-
Net Income
-
Assets & Liabilities | Cash Flow
-
Total Assets
-
Total Liabilities
-
Capital Expenditures (Capex)
-
Profitability
-
Operating Income Margin (%)
-
Net Income Margin (%)
-
EBITDA
-
Free Cash Flow (FCF)
-
Ratios
-
Return on Equity (ROE)
-
Return on Assets (ROA)
-
Debt to Equity
-
Valuation
-
Enterprise value
-
Enterprise value to Revenue
-
Enterprise value to EBITDA
Ticker
CVS
UNH
Headquarter
Woonsocket
,RI
US
Eden Prairie
,MN
US
CEO
J. David Joyner CEBS
Stephen J. Hemsley
Industry
Medical - Healthcare Plans
Medical - Healthcare Plans
Stock Price
Stock Price
Market Cap
Market Cap
$77.94 B
$218.60 B
Employees
Years
- 2022
- 2023
- 2024
- 2021
- 2022
- 2024
Employees
- 300.00 K
- 300.00 K
- 300.00 K
- 350.00 K
- 400.00 K
- 400.00 K
Y/Y
0%
0%
0%
6.06%
14.29%
0%
Income Statement
Revenue
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Revenue
- $322.47 B
- $357.78 B
- $372.81 B
- $324.16 B
- $371.62 B
- $400.28 B
Y/Y
10.39%
10.95%
4.2%
12.71%
14.64%
7.71%
Revenue by Products / Services
Revenue by Geography
Research and Development
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Research and Development
- -
- -
- -
- -
- -
- -
Y/Y
0%
0%
0%
0%
0%
0%
Operating Income
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Operating Income
- $7.95 B
- $13.74 B
- $8.52 B
- $28.44 B
- $32.36 B
- $32.29 B
Y/Y
40.24%
72.78%
38.03%
18.63%
13.8%
0.22%
Tax Rate (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Tax Rate (%)
- 26.00%
- 25.00%
- 25.00%
- 22.00%
- 21.00%
- 24.00%
Y/Y
6.95%
2.9%
1.19%
5.51%
5.31%
17.37%
Net Income
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Net Income
- $4.31 B
- $8.34 B
- $4.61 B
- $20.12 B
- $22.38 B
- $14.41 B
Y/Y
46.12%
93.55%
44.7%
16.4%
11.24%
35.64%
Revenue Per Employee
Years
- 2022
- 2023
- 2024
- 2021
- 2022
- 2024
Revenue Per Employee
- $1.07 M
- $1.19 M
- $1.24 M
- $821.71 K
- $810.41 K
- $1.00 M
Y/Y
10.39%
10.95%
4.2%
5.45%
1.38%
23.48%
Net Income Per Employee
Years
- 2022
- 2023
- 2024
- 2021
- 2022
- 2024
Net Income Per Employee
- $14.37 K
- $27.81 K
- $15.38 K
- $49.39 K
- $50.30 K
- $36.01 K
Y/Y
46.12%
93.55%
44.7%
5.81%
1.85%
28.4%
Assets & Liabilities | Cash Flow
Total Assets
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Total Assets
- $228.28 B
- $249.73 B
- $253.22 B
- $245.71 B
- $273.72 B
- $298.28 B
Y/Y
2.03%
9.4%
1.4%
15.79%
11.4%
8.97%
Total Liabilities
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Total Liabilities
- $156.51 B
- $173.09 B
- $177.49 B
- $159.36 B
- $174.80 B
- $195.69 B
Y/Y
0.71%
10.6%
2.54%
17.41%
9.69%
11.95%
Capital Expenditures (Capex)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Capital Expenditures (Capex)
- -$2.73 B
- -$3.03 B
- -$2.78 B
- -$2.80 B
- -$3.39 B
- -$3.50 B
Y/Y
8.21%
11.15%
8.25%
14.18%
20.84%
3.34%
Profitability
Operating Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Operating Income Margin (%)
- 2.47%
- 3.84%
- 2.28%
- 8.77%
- 8.71%
- 8.07%
Y/Y
45.83%
55.47%
40.63%
5.28%
0.68%
7.35%
Net Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Net Income Margin (%)
- 1.34%
- 2.33%
- 1.24%
- 6.21%
- 6.02%
- 3.60%
Y/Y
51.09%
73.88%
46.78%
3.33%
3.06%
40.2%
EBITDA
2021 | 17526000000.00 |
---|---|
2022 | 12347000000.00 |
2023 | 18197000000.00 |
2024 | 13683000000.00 |
2021 | 27073000000.00 |
---|---|
2022 | 31835000000.00 |
2023 | 32517000000.00 |
2024 | 28076000000.00 |
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
EBITDA
- $12.35 B
- $18.20 B
- $13.68 B
- $31.84 B
- $32.52 B
- $28.08 B
Y/Y
29.55%
47.38%
24.81%
17.59%
2.14%
13.66%
Free Cash Flow (FCF)
2021 | 15745000000.00 |
---|---|
2022 | 13450000000.00 |
2023 | 10395000000.00 |
2024 | 6326000000.00 |
2021 | 19889000000.00 |
---|---|
2022 | 23404000000.00 |
2023 | 25682000000.00 |
2024 | 20705000000.00 |
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Free Cash Flow (FCF)
- $13.45 B
- $10.40 B
- $6.33 B
- $23.40 B
- $25.68 B
- $20.71 B
Y/Y
14.58%
22.71%
39.14%
17.67%
9.73%
19.38%
Ratios
Return on Equity (ROE)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Return on Equity (ROE)
- 6.03%
- 10.91%
- 6.11%
- 25.87%
- 25.22%
- 15.55%
Y/Y
43.43%
80.93%
44%
7.39%
2.51%
38.34%
Return on Assets (ROA)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Return on Assets (ROA)
- 1.89%
- 3.34%
- 1.82%
- 8.19%
- 8.18%
- 4.83%
Y/Y
44.9%
76.72%
45.51%
0.49%
0.12%
40.95%
Debt to Equity
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Debt to Equity
- 98.97%
- 103.82%
- 109.74%
- 74.09%
- 75.98%
- 83.00%
Y/Y
2.23%
4.9%
5.7%
15.57%
2.55%
9.24%
Valuation
Enterprise Value
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value
- $180.05 B
- $172.65 B
- $130.85 B
- $529.45 B
- $530.57 B
- $521.54 B
Y/Y
11.16%
4.11%
24.21%
6.28%
0.21%
1.7%
Enterprise value to Revenue
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value to Revenue
- 0.56
- 0.48
- 0.35
- 1.63
- 1.43
- 1.30
Y/Y
19.52%
13.57%
27.27%
5.7%
12.59%
8.74%
Enterprise value to EBITDA
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value to EBITDA
- 14.58
- 9.49
- 9.56
- 16.63
- 16.32
- 18.58
Y/Y
26.11%
34.94%
0.79%
9.62%
1.89%
13.85%